Ep 220: David Jenkins - Dot-Com on Steroids Reality Check for the AI Era

Ep 220: David Jenkins - Dot-Com on Steroids Reality Check for the AI Era

April 13, 2026 · 52 min

About this episode

David Clark interviews David Jenkins about the implications of the AI-driven market and GQG Partners' contrarian investment strategy.

Is the current AI-driven market rally a structural revolution or a speculative mirage? David Clark sits down with David Jenkins , Client Portfolio Manager at GQG Partners , to dissect the firm's recent contrarian stance on the technology sector. Investors are feeling the squeeze of a "growth-at-any-cost" market. Jenkins explains why GQG, a firm managing over $250 billion AUD, is moving toward a defensive, value-oriented posture. We dive deep into their provocative white paper series, "Dot-Com on Steroids," exploring the "circularity" of AI capital expenditure and the looming risks in the private credit and data center boom. If you’ve been questioning the sustainability of triple-digit multiples and wondering where to find quality when "gravity" eventually returns to earnings, this conversation provides a necessary, fundamental-based reality check. Key take aways: The AI Capex Mirage: Why the massive spending by "hyperscalers" may be creating a circular revenue trap that isn't backed by real-world earnings. Quality vs. Hype: Understanding GQG’s "forward-looking quality" philosophy and why they believe traditional tech…

More episodes of Inside the Rope with David Clark

Explore listener stats, chart rankings, contacts and more on the Inside the Rope with David Clark podcast page.